Neuroinflammation and immune-brain interactions

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

358 papers

Showing 241-252 of total 358 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Biomarkers of the blood-brain barrier and the neurovascular unit and their relationship with cognitive decline and cognitive frailty.

Rodríguez-Callejas JD; Mimenza-Alvarado AJ; Lomas-Soria C; Aguilar-Navarro SG

2026PubMedDirectly related

Gut microbiota and gut-derived metabolites in defining multiple sclerosis phenotypic continuum.

Montini F; Mangalam A; Zeydan B; Murray J; Kantarci OH

Jan 1, 2026Frontiers in immunology

2026PubMedDirectly related

Neuron-derived SPP1 instructs microglia to limit degeneration.

Li S; Jakobs TC

Jan 1, 2026Science advances

2026PubMedSupporting evidence

The gut-immune-brain axis in CNS tumors: Causal roles of microbiota and inflammatory proteins unveiled by Mendelian randomization and single-cell transcriptomics.

Cao X; Guo H; Wang K; Wu Q; Wang X; Shao J

Jan 1, 2026Medicine

2026PubMedDirectly related

Microglial RIOK3 promotes post-ischemic neuroinflammation by facilitating YBX1 phosphorylation and nuclear accumulation.

Geng Y; Zong N; Zhou C; Chen J; Tang H; Sun L; Xia S; Bao X; Xu Y

Jan 1, 2026Experimental neurology

2026PubMedDirectly related

Alzheimer's disease polygenic risk score associates with hippocampal subfield atrophy and immune-related genetic mechanism.

Olivé C; de Rojas I; Zhang L; Sotolongo-Grau O; Quintela I; García-González P; Puerta R; Montrreal L; Bayón P; Rovira M; Valenzuela A; Capdevila-Bayo M; Muñoz Á; Miguel A; Calm B; Calero M; Rábano A; Belén Pastor A; Del Ser T; Medina M; Carracedo Á; Ramírez A; Molina-Porcel L; Montalbán X; Cano A; Valero S; Marquié M; Sanz P; Sánchez-Juan P; Boada M; Strange B; Fernández MV; Ruiz A

Jan 1, 2026Frontiers in aging neuroscience

2026PubMedDirectly related

From neuroinflammation to immune reprogramming: Nanozyme-Integrated nanoplatforms for neuroimmune modulation in Parkinson's disease.

Zhu S; Wang Z; Shi X; Zhong S; Ashraf GM; Fu K; Li Y

Jan 1, 2026Materials today. Bio

2026PubMedDirectly related

Microgliopathy in poststroke depression: exploring mechanisms and therapeutic strategies.

Yang C; Wu S; Cao H; Yin Y; Zhang Y; Zhang L; Chen R; Tao X

Jan 1, 2026Neuroscience

2026PubMedDirectly related

Fabrication of Mesoporous Manganese Nanoparticles Incorporated Aβ-Peptide Inhibits Aβ Aggregation and Alleviates Neuroinflammation Against Alzheimer's Disease.

Lu H; Hu C; Fu Y

Jan 1, 2026Journal of biomedical materials research. Part B, Applied biomaterials

2026CrossrefSupporting evidence0 citations

Microglia statuses in Alzheimer’s disease and lessons from anti-tumor microglia

Julia Y. Cai; Yellamandayya Vadlamudi; Praveen Agrawal

Jan 1, 2026Geromedicine

2026PubMedDirectly related

A yeast-derived postbiotic fermentate rapidly modulates inflammatory cytokines and immune surveillance markers in healthy adults: a randomized double-blind placebo-controlled cross-over trial.

Jensen GS; Cruickshank DD; Grinage EAF; Cruickshank D; Sanchez K; Garcia-Campayo V; Paton ND; Green JB

Jan 1, 2026Frontiers in nutrition

2026PubMedDirectly related

Crosstalk Between Oligodendrocyte Lineage Cells and CNS-Resident and Peripheral Immune Cells Governs Demyelination and Remyelination in Multiple Sclerosis.

Park J; Cheon SY; Guo F

Jan 1, 2026Glia